XML 40 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Information
9 Months Ended
Dec. 31, 2013
Segment Information  
Segment Information

Note 8 - Segment Information

 

Prior to the November 2013 acquisitions of TempSys and Amega, we had two reporting segments:  Biological Indicators and Instruments.  As a result of these acquisitions we added a third reporting segment, Continuous Monitoring.  The following tables set forth our segment information (in thousands):

 

 

 

Three Months Ended December 31, 2013

 

 

 

Biological 
Indicators

 

Instruments

 

Continuous 
Monitoring

 

Total

 

Revenues

 

$

5,317

 

$

6,438

 

$

1,361

 

$

13,116

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

$

2,976

 

$

4,137

 

$

593

 

$

7,706

 

Selling expenses

 

404

 

1,047

 

144

 

1,595

 

 

 

$

2,572

 

$

3,090

 

$

449

 

6,111

 

Reconciling items (1)

 

 

 

 

 

 

 

(3,384

)

Earnings before income taxes

 

 

 

 

 

 

 

$

2,727

 

 

 

 

Three Months Ended December 31, 2012

 

 

 

Biological 
Indicators

 

Instruments

 

Continuous 
Monitoring

 

Total

 

Revenues

 

$

5,154

 

$

6,207

 

 

$

11,361

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

$

2,936

 

$

4,011

 

 

$

6,947

 

Selling expenses

 

385

 

838

 

 

1,223

 

 

 

$

2,551

 

$

3,173

 

 

5,724

 

Reconciling items (1)

 

 

 

 

 

 

 

(3,298

)

Earnings before income taxes

 

 

 

 

 

 

 

$

2,426

 

 

 

 

Nine Months Ended December 31, 2013

 

 

 

Biological 
Indicators

 

Instruments

 

Continuous 
Monitoring

 

Total

 

Revenues

 

$

16,181

 

$

19,468

 

$

1,361

 

$

37,010

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

$

9,019

 

$

12,491

 

$

593

 

$

22,103

 

Selling expenses

 

1,350

 

2,603

 

144

 

4,097

 

 

 

$

7,669

 

$

9,888

 

$

449

 

18,006

 

Reconciling items (1)

 

 

 

 

 

 

 

(9,326

)

Earnings before income taxes

 

 

 

 

 

 

 

$

8,680

 

 

 

 

Nine Months Ended December 31, 2012

 

 

 

Biological 
Indicators

 

Instruments

 

Continuous 
Monitoring

 

Total

 

Revenues

 

$

15,590

 

$

18,037

 

 

$

33,627

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

$

8,890

 

$

11,761

 

 

$

20,651

 

Selling expenses

 

1,165

 

2,132

 

 

3,297

 

 

 

$

7,725

 

$

9,629

 

 

17,354

 

Reconciling items (1)

 

 

 

 

 

 

 

(8,290

)

Earnings before income taxes

 

 

 

 

 

 

 

$

9,064

 

 

(1) Reconciling items include general and administrative, research and development, and other expenses.

 

 

 

December 31, 2013

 

March 31, 2013

 

Total assets

 

 

 

 

 

Biological Indicators

 

$

25,710

 

$

27,558

 

Instruments

 

33,759

 

31,782

 

Continuous Monitoring

 

28,485

 

 

Corporate and administrative

 

4,601

 

6,579

 

 

 

$

92,555

 

$

65,919

 

 

All long-lived assets are located in the United States.

 

Revenues from external customers are attributed to individual countries based upon locations to which the product is shipped or exported, as follows (in thousands):

 

 

 

Three Months Ended 
December 31,

 

Nine Months Ended 
December 31,

 

 

 

2013

 

2012

 

2013

 

2012

 

Net revenues from unaffiliated customers:

 

 

 

 

 

 

 

 

 

United States

 

$

7,054

 

$

7,013

 

$

20,877

 

$

20,504

 

Foreign

 

6,062

 

4,348

 

16,133

 

13,123

 

 

 

$

13,116

 

$

11,361

 

$

37,010

 

$

33,627

 

 

No foreign country exceeds 10% of total revenues.